SCHEMBL30867441

SCHEMBL30867441

Cc1c(Br)cnc(Cl)c1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
SIRT6 Q8N6T7 1/20 0.35
TSHR P16473 2/20 0.33
NNMT P40261 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
MC4R P32245 1/20 0.32
ADRA1A P35348 1/20 0.32
MC3R P41968 1/20 0.32
CYP2C9 P11712 1/20 0.32
PKMYT1 Q99640 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NTRK1 P04629 2/20 0.31
PIM1 P11309 2/20 0.31
ACVR1 Q04771 2/20 0.31
PLAU P00749 2/20 0.31
MAPT P10636 1/20 0.31
MAP4K4 O95819 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31459178 0.84 ALDH1A1 (0.42) HSD17B10
SCHEMBL3450931 0.84 ALDH1A1 (0.42) HSD17B10
SCHEMBL27448979 0.81 POLB (0.50) POLBSIRT6TSHRNNMTCYP2C9
SCHEMBL28475154 0.81 POLB (0.46) POLBSIRT6TSHRNNMTCYP2C9
SCHEMBL27344813 0.81 POLB (0.34) POLBSIRT6TSHRNNMTADORA3
SCHEMBL24683791 0.79 TSHR (0.37) TSHRHSD17B10MAPT
SCHEMBL28883340 0.79 CNR1 (0.32) POLBADORA3
SCHEMBL4144902 0.79 POLB (0.43) POLBSIRT6TSHRNNMTCYP2C9
Hydrochloric Acid SCHEMBL5253403 0.79 PIK3CB (0.35) POLBTSHRNNMTADORA3MC4R
Nitrous Acid SCHEMBL28883343 0.78 ALDH1A1 (0.41) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583867-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Latigo Biotherapeutics, Inc. (US) 2025-07-16 EP disclosed
WO-2024054622-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2024-03-14 WO disclosed